Environmental and genetic factors may modify or contribute to the phenotypic differences observed in multigenic and monogenic diseases, such as cystic fibrosis (CF). An analysis of modifier genes can be helpful for estimating patient prognosis and directing preventive care. The aim of this study is to determine the association between seven genetic variants of four modifier genes and CF by comparing their corresponding allelic and genotypic frequencies in CF patients (n = 81) and control subjects (n = 104). Genetic variants of MBL2 exon 1 (A, B, C and D), the IL-8 promoter (2251 A/T), the TNFa promoter (TNF1/TNF2), and SERPINA1 (PI*Z and PI*S) were tested in CF patients and control subjects from northeastern Mexico by PCR-RFLP. Results: The...
In the past two years we have developed a biological bank of genomic DNA, cDNA, serum and red blood ...
More than 1,000 mutations have been identified in the cystic fibrosis (CF) transmembrane regulator (...
More than 1,000 mutations have been identified in the cystic fibrosis (CF) transmembrane regulator (...
Environmental and genetic factors may modify or contribute to the phenotypic differences observed in...
Environmental and genetic factors may modify or contribute to the phenotypic differences observed in...
Environmental and genetic factors may modify or contribute to the phenotypic differences observed in...
AbstractThe variation in cystic fibrosis (CF) lung disease and development of CF related complicatio...
Cystic fibrosis (CF) is a monogenic autosomal recessive disease caused by cystic fibrosis transmembr...
Abstract The availability of molecular tools to carry out genotyping has led to a flurry of associat...
Cystic Fibrosis is one of the most common genetic recessive diseases among Caucasians and is caused ...
The severity of cystic fibrosis (CF) is associated with classes of mutations in the CFTR gene (cysti...
Cystic fibrosis pulmonary disease is characterized by excessive and prolonged inflammation. CF Pulmo...
Understanding the causes of variation in clinical manifestations of disease should allow for design ...
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Fundação de Amparo à Pesquisa do Estado...
Technological advances in genetics have made feasible and affordable large studies to identify genet...
In the past two years we have developed a biological bank of genomic DNA, cDNA, serum and red blood ...
More than 1,000 mutations have been identified in the cystic fibrosis (CF) transmembrane regulator (...
More than 1,000 mutations have been identified in the cystic fibrosis (CF) transmembrane regulator (...
Environmental and genetic factors may modify or contribute to the phenotypic differences observed in...
Environmental and genetic factors may modify or contribute to the phenotypic differences observed in...
Environmental and genetic factors may modify or contribute to the phenotypic differences observed in...
AbstractThe variation in cystic fibrosis (CF) lung disease and development of CF related complicatio...
Cystic fibrosis (CF) is a monogenic autosomal recessive disease caused by cystic fibrosis transmembr...
Abstract The availability of molecular tools to carry out genotyping has led to a flurry of associat...
Cystic Fibrosis is one of the most common genetic recessive diseases among Caucasians and is caused ...
The severity of cystic fibrosis (CF) is associated with classes of mutations in the CFTR gene (cysti...
Cystic fibrosis pulmonary disease is characterized by excessive and prolonged inflammation. CF Pulmo...
Understanding the causes of variation in clinical manifestations of disease should allow for design ...
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Fundação de Amparo à Pesquisa do Estado...
Technological advances in genetics have made feasible and affordable large studies to identify genet...
In the past two years we have developed a biological bank of genomic DNA, cDNA, serum and red blood ...
More than 1,000 mutations have been identified in the cystic fibrosis (CF) transmembrane regulator (...
More than 1,000 mutations have been identified in the cystic fibrosis (CF) transmembrane regulator (...